For newborns, phototherapy is the most common treatment
This phase 2 study compared brodalumab against placebo in patients with active PsA (both non-exposed and exposed to prior biologic therapy) to a primary endpoint of 20% improvement of American College of Rheumatology (ACR) criteria at week 12
Peptides are one part of a multi-phase plan, not a standalone fix
BPC-157 is a synthetic pentadecapeptide research reagent supplied in lyophilized powder form
Also very curious how other clinicians are handling this conversation, especially in acute injury versus chronic pain
Apr 28th, 2026 How TB-500 Promotes Recovery and Angiogenesis TB-500 is a synthetic fragment of thymosin beta-4 associated with tissue repair and angiogenesis, but human evidence is limited, it is not FDA-approved, and its safety and effectiveness remain uncertain